0,896  0,006  Transcription factor NF kappa B inhibitor
0,844  0,004  Sensitization
0,837  0,004  Caspase 3 stimulant
0,808  0,016  Apoptosis agonist
0,767  0,020  Antiinflammatory
0,743  0,005  Antioxidant
0,738  0,005  CTGF expression inhibitor
0,731  0,008  Chemoprotective
0,727  0,009  Chemopreventive
0,706  0,012  Antileukemic
0,698  0,005  Antipyretic
0,694  0,005  Free radical scavenger
0,680  0,003  Melanin inhibitor
0,673  0,002  Alcohol dehydrogenase substrate
0,665  0,007  Nitric oxide antagonist
0,633  0,004  Skin whitener
0,657  0,029  Caspase 9 stimulant
0,619  0,006  Antimutagenic
0,615  0,005  Genotoxic
0,612  0,006  UGT1A1 substrate
0,605  0,012  Proliferative diseases treatment
0,599  0,010  Apoptosis antagonist
0,593  0,008  Hypoglycemic
0,593  0,012  UGT1A9 substrate
0,563  0,014  AR expression inhibitor
0,558  0,018  Bone diseases treatment
0,535  0,004  5 Hydroxytryptamine uptake stimulant
0,536  0,005  Amylase inhibitor
0,545  0,014  NOS2 expression inhibitor
0,543  0,015  Antiosteoporotic
0,530  0,009  Antihypertriglyceridemic
0,529  0,015  Antineoplastic (multiple myeloma)
0,514  0,007  Monophenol monooxygenase inhibitor
0,543  0,045  Antineoplastic (breast cancer)
0,520  0,021  CYP1A2 substrate
0,519  0,022  Cytotoxic
0,525  0,028  Prostate cancer treatment
0,508  0,021  Hepatic disorders treatment
0,524  0,040  TNF expression inhibitor
0,486  0,008  Hepatoprotectant
0,480  0,004  Neurotrophic factor enhancer
0,480  0,008  UGT1A3 substrate
0,488  0,018  Antiprotozoal (Leishmania)
0,507  0,038  Antibacterial
0,479  0,017  Antineoplastic (glioblastoma multiforme)
0,480  0,022  Antineoplastic (glioma)
0,465  0,007  Platelet adhesion inhibitor
0,480  0,022  Mutagenic
0,480  0,026  Antineoplastic (melanoma)
0,480  0,030  CYP2C19 substrate
0,446  0,001  Aldehyde dehydrogenase substrate
0,462  0,018  Tumour necrosis factor alpha release inhibitor
0,475  0,040  Antineoplastic (colorectal cancer)
0,457  0,040  Antineoplastic (colon cancer)
0,449  0,034  Antihypercholesterolemic
0,415  0,023  Amyloid beta aggregation inhibitor
0,396  0,009  GST P1-1 substrate
0,415  0,030  Antineoplastic (non-small cell lung cancer)
0,416  0,034  Lipoxygenase inhibitor
0,415  0,035  Cardioprotectant
0,435  0,056  GST A substrate
0,420  0,049  Vasodilator, peripheral
0,380  0,011  VCAM1 expression inhibitor
0,406  0,038  Antineoplastic (brain cancer)
0,395  0,032  UGT2B4 substrate
0,403  0,044  Teratogen
0,419  0,061  Antineoplastic (lung cancer)
0,397  0,039  NOS3 expression inhibitor
0,389  0,038  Antineoplastic (cervical cancer)
0,396  0,045  Antineoplastic (ovarian cancer)
0,398  0,050  Antithrombotic
0,361  0,016  UGT2B7 substrate
0,387  0,042  Radioprotector
0,352  0,008  Glutathione S-transferase substrate
0,365  0,024  UDP-glucuronosyltransferase substrate
0,343  0,006  Neurotrophic factor
0,347  0,014  Pneumotoxic
0,394  0,064  CYP3A4 substrate
0,366  0,036  Carcinogenic
0,353  0,035  Antineoplastic (renal cancer)
0,324  0,008  Aldose reductase substrate
0,349  0,033  Vasodilator
0,369  0,053  ICAM1 expression inhibitor
0,349  0,040  Antihypoxic
0,341  0,035  UGT1A6 substrate
0,354  0,049  Embryotoxic
0,342  0,038  Superoxide dismutase inhibitor
0,375  0,072  CYP2C9 substrate
0,359  0,058  Antifungal
0,326  0,035  Antiulcerative
0,321  0,033  Antineoplastic (sarcoma)
0,344  0,060  CYP2D6 substrate
0,297  0,022  Antineoplastic (squamous cell carcinoma)
0,303  0,029  Antihypotensive
0,292  0,019  UGT2B15 substrate
0,261  0,011  Xanthine oxidase inhibitor
0,271  0,023  Tubulin antagonist
0,307  0,066  Antineoplastic (pancreatic cancer)
0,294  0,055  Platelet antagonist
0,252  0,017  Cholesterol synthesis inhibitor
0,239  0,004  Estrogen receptor beta agonist
0,258  0,024  Protein kinase stimulant
0,241  0,009  Carbonic anhydrase XIII inhibitor
0,247  0,023  Succinate dehydrogenase inhibitor
0,232  0,010  Estrogen antagonist
0,346  0,125  Antidiabetic
0,346  0,125  Cyclophilin D inhibitor
0,276  0,060  Vascular (periferal) disease treatment
0,288  0,075  Spasmolytic
0,221  0,008  Estrogen receptor beta antagonist
0,236  0,025  UGT2B9 substrate
0,225  0,016  Antihemorrhagic
0,307  0,100  Stroke treatment
0,250  0,045  Antihelmintic
0,220  0,020  Cystathionine beta-synthase inhibitor
0,222  0,033  NOS3 expression enhancer
0,305  0,121  Histamine release inhibitor
0,197  0,013  HDL-cholesterol increasing
0,189  0,009  Estrogen agonist
0,243  0,064  Antiparasitic
0,282  0,103  Vasodilator, coronary
0,265  0,088  Hypoxia-inducible factor 1 alpha inhibitor
0,207  0,032  UGT2B10 substrate
0,234  0,066  Antimitotic
0,217  0,050  Antipruritic, non-allergic
0,238  0,071  Antineoplastic (lymphoma)
0,291  0,127  Antipruritic, allergic
0,270  0,109  Angiogenesis inhibitor
0,210  0,054  UGT1A4 substrate
0,168  0,013  Toll-Like receptor 4 antagonist
0,204  0,050  Eye irritation, high
0,198  0,047  Restenosis treatment
0,230  0,079  Angiogenesis stimulant
0,207  0,059  P-glycoprotein inhibitor
0,174  0,030  5-Lipoxygenase inhibitor
0,169  0,025  Bronchodilator
0,183  0,040  Antinephritic
0,150  0,007  Xanthine dehydrogenase inhibitor
0,154  0,013  HIV-1 integrase (3'-Processing) inhibitor
0,240  0,100  Immunostimulant
0,149  0,009  Alpha tubulin antagonist
0,245  0,107  Antiischemic
0,166  0,029  Expectorant
0,185  0,050  Antineoplastic (carcinoma)
0,192  0,058  Tumour necrosis factor antagonist
0,136  0,005  Estrogen receptor alpha agonist
0,238  0,108  Respiratory analeptic
0,156  0,028  Constipation treatment
0,173  0,045  Bone formation stimulant
0,248  0,120  Antineoplastic (osteosarcoma)
0,153  0,027  Sulfotransferase substrate
0,147  0,025  Breast cancer-resistant protein inhibitor
0,139  0,018  Opioid kappa receptor antagonist
0,152  0,032  Antineoplastic (uterine cancer)
0,145  0,027  Beta glucuronidase inhibitor
0,140  0,023  Factor V inhibitor
0,192  0,076  Sedative
0,150  0,034  Papain-like protease (SARS coronavirus) inhibitor
0,159  0,044  Skin irritative effect
0,145  0,031  UGT2B1 substrate
0,168  0,057  Lipid peroxidase inhibitor
0,220  0,109  Lipoprotein disorders treatment
0,288  0,178  Alzheimer's disease treatment
0,124  0,016  HIV-1 integrase (Strand Transfer) inhibitor
0,226  0,119  Analeptic
0,131  0,025  NAD(P)H dehydrogenase (quinone) inhibitor
0,151  0,046  Alkylator
0,219  0,116  CYP1A2 inhibitor
0,263  0,160  CYP2C19 inhibitor
0,129  0,027  UGT2B11 substrate
0,137  0,036  Carbonic anhydrase XV inhibitor
0,171  0,073  Liver fibrosis treatment
0,116  0,018  Na+ K+ transporting ATPase inhibitor
0,237  0,142  Sodium/bile acid cotransporter inhibitor
0,160  0,066  Interferon gamma antagonist
0,119  0,026  Ornithine decarboxylase inhibitor
0,144  0,053  DNA polymerase I inhibitor
0,168  0,080  Antineoplastic (bone cancer)
0,139  0,052  Vanilloid 1 agonist
0,171  0,084  LDLR expression enhancer
0,125  0,040  Dementia treatment
0,143  0,058  Antiseptic
0,116  0,031  Topoisomerase II alpha inhibitor
0,157  0,072  Protein-tyrosine phosphatase inhibitor
0,149  0,066  SULT1A3 substrate
0,120  0,039  Vascular dementia treatment
0,133  0,053  Interleukin 1b antagonist
0,104  0,025  Estrogen receptor alpha antagonist
0,127  0,048  Gout treatment
0,122  0,044  Electron transport complex I inhibitor
0,153  0,076  Antiviral (Herpes)
0,094  0,019  Aldose reductase inhibitor
0,128  0,053  Microtubule formation inhibitor
0,109  0,034  Carbonic anhydrase VI inhibitor
0,195  0,125  Antiprotozoal (Trypanosoma)
0,164  0,096  Antirickettsial
0,200  0,133  Transcription factor STAT3 inhibitor
0,087  0,020  Postmenopausal disorders treatment
0,120  0,055  Mucolytic
0,078  0,013  Opioid kappa receptor agonist
0,179  0,115  Antiamyloidogenic
0,074  0,014  Glucose-6-phosphate translocase inhibitor
0,097  0,037  3C-Like protease (SARS coronavirus) inhibitor
0,094  0,036  Thioredoxin reductase inhibitor
0,156  0,099  Toxic, respiratory center
0,117  0,061  TRPA1 agonist
0,088  0,033  HIV-1 integrase inhibitor
0,087  0,033  Leukotriene synthesis inhibitor
0,125  0,072  Toll-Like receptor 2 antagonist
0,080  0,028  Aromatase inhibitor
0,076  0,025  Transcription factor AP-1 inhibitor
0,080  0,029  Beta tubulin antagonist
0,180  0,129  Antineoplastic (liver cancer)
0,169  0,118  VEGF expression inhibitor
0,105  0,056  Carbonic anhydrase III inhibitor
0,086  0,037  Lipase inhibitor
0,118  0,072  M18 aspartyl aminopeptidase inhibitor
0,126  0,082  Antifungal enhancer
0,220  0,176  Immunosuppressant
0,229  0,186  Antiprotozoal
0,095  0,052  Opioid antagonist
0,165  0,122  Hypolipemic
0,091  0,050  Antineoplastic antibiotic
0,168  0,127  Antineoplastic (lymphocytic leukemia)
0,097  0,056  Uric acid excretion stimulant
0,071  0,031  CDK4/cyclin D1 inhibitor
0,134  0,094  Antidiarrheal
0,115  0,077  Antiviral (Influenza B)
0,105  0,067  Choleretic
0,072  0,038  Leukotriene antagonist
0,209  0,176  GST M1-1 substrate
0,093  0,061  ABCA1 expression enhancer
0,148  0,117  Antiviral (Influenza)
0,109  0,078  Topoisomerase II inhibitor
0,219  0,191  Antineoplastic (endocrine cancer)
0,060  0,034  Postcoital contraceptive
0,146  0,120  Non-steroidal antiinflammatory agent
0,114  0,089  Gastritis treatment
0,084  0,059  Vanilloid agonist
0,105  0,081  Proteasome inhibitor
0,144  0,121  Psychostimulant
0,075  0,054  Antitreponemal
0,141  0,125  DNA methylase inhibitor
0,096  0,082  Protein-tyrosine phosphatase 1B inhibitor
0,064  0,050  Opioid mu receptor antagonist
0,107  0,094  Cyclooxygenase 3 inhibitor
0,061  0,049  CDC25B inhibitor
0,049  0,038  Factor III inhibitor
0,045  0,034  Opioid mu receptor agonist
0,125  0,114  Muscle relaxant
0,050  0,040  Protein 50S ribosomal subunit inhibitor
0,174  0,163  DNA synthesis inhibitor
0,068  0,058  Antibiotic
0,034  0,025  Tubulin agonist
0,068  0,060  CDC25A inhibitor
0,056  0,049  Opioid delta receptor antagonist
0,024  0,018  Sodium/glucose cotransporter 1 inhibitor
0,118  0,113  Skeletal muscle relaxant
0,184  0,180  Cholesterol antagonist
0,030  0,027  Catechol O-methyltransferase inhibitor
0,143  0,142  Insulin sensitizer

